Pharmaceutical Market Research
Pharmaceutical research has to move fluently between clinical, regulatory and commercial domains, while respecting the ethical and compliance constraints that define the industry. Meraki Research works with originators, generics companies, biosimilar developers and distributors across South Africa and the continent, producing research that meets both commercial decision-makers and medical affairs teams where they operate.
Why Pharmaceutical Research Matters
- SAHPRA processes and post-approval monitoring shape commercial planning in ways that generic market research does not capture.
- Prescriber research requires compliance-aware design — SAMED and self-regulation codes set the boundaries of permissible engagement.
- Access, reimbursement and formulary dynamics across private medical schemes, the public sector and NHI are moving targets.
- Generic and biosimilar competition patterns differ across African markets, and pricing and tender strategies have to reflect those differences.
- Patient research in therapeutic areas requires ethical clearance and specific consent handling that most commercial agencies are not set up to provide.
Our Pharmaceutical Research Services
Prescriber and HCP Research
Compliance-aware research with prescribers across private and public-sector practice, covering treatment algorithms, switching behaviour and brand perception.
Patient and Caregiver Research
Ethically cleared research with patients and caregivers in specific therapeutic areas, including burden-of-disease work, adherence research and patient-reported outcomes.
Market Access and Reimbursement Research
Research with medical scheme staff, brokers, pharmacists and public-sector procurement, covering formulary behaviour, tender dynamics and access barriers.
Brand and Portfolio Research
Brand tracker, message testing and positioning research adapted for the pharmaceutical regulatory context.
Launch and Readiness Research
Pre-launch research covering prescriber awareness, advocacy readiness and access-pathway validation ahead of SAHPRA approval milestones.
Competitive Intelligence
Structured primary-sourced intelligence on competitor portfolios, pipeline, tender behaviour and pricing across priority African markets.
How We Approach Research in This Sector
Pharmaceutical research protocols are non-negotiable — ethical clearance, adverse-event handling, code-compliant engagement and POPIA-aligned data handling are built into every engagement. Our teams understand the clinical and commercial context well enough that follow-up questions are substantive rather than scripted, and we deliver research in formats both medical affairs and commercial audiences can use.
Why Choose Meraki Research for Pharmaceutical?
- Senior researchers with direct pharmaceutical commercial experience, including in-market roles with originator and generics companies.
- Ethical clearance processes established for patient-facing research across major therapeutic areas.
- Prescriber panels across SA and major African markets, covering generalists and specialists.
- Familiarity with the current SAHPRA, SAMED and medical-scheme regulatory landscape.
What We Deliver
| Deliverable | Format | Typical Timeline |
|---|---|---|
| Prescriber Research Report | PDF + clip library | Week 5 |
| Patient Research Readout | Slide deck + narrative | Week 6 |
| Market Access Briefing | PDF + workbook | Week 7 |
| Competitive Intelligence Set | PDF reports | Week 8 |
| Launch Readiness Memo | PDF + checklist | Week 9 |